Mannitol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mannitol" in English language version.

refsWebsite

Global rank English rank

15doi.org

2^nd place

15nih.gov

4^th place

9web.archive.org

1^st place

7semanticscholar.org

11^th place

8^th place

4books.google.com

3^rd place

2handle.net

102^nd place

76^th place

2zenodo.org

621^st place

380^th place

2fda.gov

447^th place

338^th place

1hres.ca

low place

1europa.eu

68^th place

117^th place

1drugs.com

399^th place

333^rd place

1bronchitol.com

low place

1wada-ama.org

9,542^nd place

8,313^th place

1mayoclinic.org

1,610^th place

1,279^th place

1jbc.org

4,455^th place

5,199^th place

1archive.org

6^th place

1vice.com

175^th place

137^th place

1pharmacopoeia.co.uk

low place

1nihs.go.jp

low place

1usp.org

low place

archive.org

Weiner ML, Kotkoskie LA (1999). Excipient Toxicity and Safety. Taylor & Francis. pp. 370. ISBN 9780824782108.

books.google.com

Varzakas T, Labropoulos A, Anestis S (2012). Sweeteners: Nutritional Aspects, Applications, and Production Technology. CRC Press. pp. 59–60. ISBN 9781439876732. Archived from the original on 10 September 2017.
Kremers E, Sonnedecker G (1986). Kremers and Urdang's History of Pharmacy. Amer. Inst. History of Pharmacy. p. 360. ISBN 9780931292170. Archived from the original on 10 September 2017.
Cottrell JE, Patel P (2016). Cottrell and Patel's Neuroanesthesia. Elsevier Health Sciences. p. 160. ISBN 9780323461122.
Bardal S, Waechter J, Martin D (2010). Applied Pharmacology. Elsevier Health Sciences. p. 411. ISBN 978-1437735789.

bronchitol.com

"BRONCHITOL® (mannitol) inhalation powder Patient Site". bronchitol.com.

doi.org

Wakai A, McCabe A, Roberts I, Schierhout G (August 2013). "Mannitol for acute traumatic brain injury". The Cochrane Database of Systematic Reviews. 2013 (8): CD001049. doi:10.1002/14651858.CD001049.pub5. PMC 7050611. PMID 23918314.
Gu, J., Huang, H., Huang, Y. et al. Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials. Neurosurg Rev 42, 499–509 (2019). https://doi.org/10.1007/s10143-018-0991-8
Rapoport SI (April 2000). "Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications". Cellular and Molecular Neurobiology. 20 (2): 217–230. doi:10.1023/a:1007049806660. PMID 10696511. S2CID 20258642.
Linville RM, DeStefano JG, Sklar MB, Chu C, Walczak P, Searson PC (July 2020). "Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels". Journal of Cerebral Blood Flow and Metabolism. 40 (7): 1517–1532. doi:10.1177/0271678X19867980. PMC 7308510. PMID 31394959. S2CID 199507024.
Ellis FW, Krantz JC (1941). "Sugar alcohols: XXII. Metabolism and toxicity studies with mannitol and sorbitol in man and animals". J. Biol. Chem. 141: 147–154. doi:10.1016/S0021-9258(18)72829-9. Archived from the original on 10 September 2017.
Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM (September 2011). "Accuracy of eucapnic hyperpnea or mannitol to diagnose exercise-induced bronchoconstriction: a systematic review". Annals of Allergy, Asthma & Immunology. 107 (3): 229–34.e8. doi:10.1016/j.anai.2011.06.013. PMID 21875541.
Song SH, Vieille C (August 2009). "Recent advances in the biological production of mannitol". Applied Microbiology and Biotechnology. 84 (1): 55–62. doi:10.1007/s00253-009-2086-5. PMID 19578847. S2CID 42103028.
Ghoreishi SM, Shahrestani RG (2009). "Innovative strategies for engineering mannitol production". Trends in Food Science & Technology. 20 (6–7): 263–270. doi:10.1016/j.tifs.2009.03.006.
Wagner H, Flachsbarth H, Vogel G (March 1981). "[A New Antiphlogistic Principle from Sabal serrulata, II]". Planta Medica. 41 (3): 252–8. doi:10.1055/s-2007-971711. PMID 17401849. S2CID 260249165.
Domac J (1881). "Über das Hexylen aus Mannit". Monatshefte für Chemie (in German). 2: 309–322. doi:10.1007/BF01516516. S2CID 94940823.
Domac J (1882). "II. Ueber die Einwirkung der Unterchlorsäure auf Hexylen". Justus Liebig's Annalen der Chemie (in German). 213: 124–132. doi:10.1002/jlac.18822130107.
Cruz J, Minoja G, Okuchi K (October 2001). "Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial". Neurosurgery. 49 (4): 864–71. doi:10.1097/00006123-200110000-00016. PMID 11564247. S2CID 43880412.
Cruz J, Minoja G, Okuchi K (September 2002). "Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial". Neurosurgery. 51 (3): 628–37, discussion 637–8. doi:10.1097/00006123-200209000-00006. PMID 12188940. S2CID 20678448.
Cruz J, Minoja G, Okuchi K, Facco E (March 2004). "Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial". Journal of Neurosurgery. 100 (3): 376–83. doi:10.3171/jns.2004.100.3.0376. PMID 15035271.
Roberts I, Smith R, Evans S (February 2007). "Doubts over head injury studies". BMJ. 334 (7590): 392–4. doi:10.1136/bmj.39118.480023.BE. PMC 1804156. PMID 17322250.

drugs.com

"Mannitol". The American Society of Health-System Pharmacists. Archived from the original on 26 May 2015. Retrieved 8 January 2015.

europa.eu

ema.europa.eu

"Bronchitol EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 28 October 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

fda.gov

"Select Committee on GRAS Substances (SCOGS) Opinion: Mannitol". FDA.gov. April 2013. Archived from the original on 22 October 2014.

handle.net

hdl.handle.net

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 332. hdl:10665/44053. ISBN 9789241547659.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

hres.ca

hpr-rps.hres.ca

"Regulatory Decision Summary - Aridol". Health Canada. 23 October 2014. Retrieved 7 June 2022.

jbc.org

Ellis FW, Krantz JC (1941). "Sugar alcohols: XXII. Metabolism and toxicity studies with mannitol and sorbitol in man and animals". J. Biol. Chem. 141: 147–154. doi:10.1016/S0021-9258(18)72829-9. Archived from the original on 10 September 2017.

mayoclinic.org

"Mannitol (Intravenous Route)". Mayo Clinic.

nih.gov

pubmed.ncbi.nlm.nih.gov

Wakai A, McCabe A, Roberts I, Schierhout G (August 2013). "Mannitol for acute traumatic brain injury". The Cochrane Database of Systematic Reviews. 2013 (8): CD001049. doi:10.1002/14651858.CD001049.pub5. PMC 7050611. PMID 23918314.
Rapoport SI (April 2000). "Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications". Cellular and Molecular Neurobiology. 20 (2): 217–230. doi:10.1023/a:1007049806660. PMID 10696511. S2CID 20258642.
Linville RM, DeStefano JG, Sklar MB, Chu C, Walczak P, Searson PC (July 2020). "Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels". Journal of Cerebral Blood Flow and Metabolism. 40 (7): 1517–1532. doi:10.1177/0271678X19867980. PMC 7308510. PMID 31394959. S2CID 199507024.
Stickland MK, Rowe BH, Spooner CH, Vandermeer B, Dryden DM (September 2011). "Accuracy of eucapnic hyperpnea or mannitol to diagnose exercise-induced bronchoconstriction: a systematic review". Annals of Allergy, Asthma & Immunology. 107 (3): 229–34.e8. doi:10.1016/j.anai.2011.06.013. PMID 21875541.
Song SH, Vieille C (August 2009). "Recent advances in the biological production of mannitol". Applied Microbiology and Biotechnology. 84 (1): 55–62. doi:10.1007/s00253-009-2086-5. PMID 19578847. S2CID 42103028.
Wagner H, Flachsbarth H, Vogel G (March 1981). "[A New Antiphlogistic Principle from Sabal serrulata, II]". Planta Medica. 41 (3): 252–8. doi:10.1055/s-2007-971711. PMID 17401849. S2CID 260249165.
Inić S, Kujundžić N (2011). "The first independent pharmacognosy institute in the world and its founder Julije Domac (1853–1928)". Die Pharmazie (in German). 66 (6): 720–726. PMID 22026131.
Cruz J, Minoja G, Okuchi K (October 2001). "Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial". Neurosurgery. 49 (4): 864–71. doi:10.1097/00006123-200110000-00016. PMID 11564247. S2CID 43880412.
Cruz J, Minoja G, Okuchi K (September 2002). "Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial". Neurosurgery. 51 (3): 628–37, discussion 637–8. doi:10.1097/00006123-200209000-00006. PMID 12188940. S2CID 20678448.
Cruz J, Minoja G, Okuchi K, Facco E (March 2004). "Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial". Journal of Neurosurgery. 100 (3): 376–83. doi:10.3171/jns.2004.100.3.0376. PMID 15035271.
Roberts I, Smith R, Evans S (February 2007). "Doubts over head injury studies". BMJ. 334 (7590): 392–4. doi:10.1136/bmj.39118.480023.BE. PMC 1804156. PMID 17322250.

ncbi.nlm.nih.gov

Wakai A, McCabe A, Roberts I, Schierhout G (August 2013). "Mannitol for acute traumatic brain injury". The Cochrane Database of Systematic Reviews. 2013 (8): CD001049. doi:10.1002/14651858.CD001049.pub5. PMC 7050611. PMID 23918314.
Linville RM, DeStefano JG, Sklar MB, Chu C, Walczak P, Searson PC (July 2020). "Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels". Journal of Cerebral Blood Flow and Metabolism. 40 (7): 1517–1532. doi:10.1177/0271678X19867980. PMC 7308510. PMID 31394959. S2CID 199507024.
Roberts I, Smith R, Evans S (February 2007). "Doubts over head injury studies". BMJ. 334 (7590): 392–4. doi:10.1136/bmj.39118.480023.BE. PMC 1804156. PMID 17322250.

dailymed.nlm.nih.gov

"Osmitrol- mannitol injection, solution". DailyMed. 15 November 2018. Retrieved 28 October 2020.

nihs.go.jp

jpdb.nihs.go.jp

"Japanese Pharmacopoeia, Fifteenth Edition" (PDF). 2006. Archived from the original (PDF) on 22 July 2011. Retrieved 31 January 2010.

pharmacopoeia.co.uk

British Pharmacopoeia Commission Secretariat (2009). "Index, BP 2009" (PDF). Archived from the original (PDF) on 11 April 2009. Retrieved 31 January 2010.

semanticscholar.org

api.semanticscholar.org

Rapoport SI (April 2000). "Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications". Cellular and Molecular Neurobiology. 20 (2): 217–230. doi:10.1023/a:1007049806660. PMID 10696511. S2CID 20258642.
Linville RM, DeStefano JG, Sklar MB, Chu C, Walczak P, Searson PC (July 2020). "Modeling hyperosmotic blood-brain barrier opening within human tissue-engineered in vitro brain microvessels". Journal of Cerebral Blood Flow and Metabolism. 40 (7): 1517–1532. doi:10.1177/0271678X19867980. PMC 7308510. PMID 31394959. S2CID 199507024.
Song SH, Vieille C (August 2009). "Recent advances in the biological production of mannitol". Applied Microbiology and Biotechnology. 84 (1): 55–62. doi:10.1007/s00253-009-2086-5. PMID 19578847. S2CID 42103028.
Wagner H, Flachsbarth H, Vogel G (March 1981). "[A New Antiphlogistic Principle from Sabal serrulata, II]". Planta Medica. 41 (3): 252–8. doi:10.1055/s-2007-971711. PMID 17401849. S2CID 260249165.
Domac J (1881). "Über das Hexylen aus Mannit". Monatshefte für Chemie (in German). 2: 309–322. doi:10.1007/BF01516516. S2CID 94940823.
Cruz J, Minoja G, Okuchi K (October 2001). "Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial". Neurosurgery. 49 (4): 864–71. doi:10.1097/00006123-200110000-00016. PMID 11564247. S2CID 43880412.
Cruz J, Minoja G, Okuchi K (September 2002). "Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial". Neurosurgery. 51 (3): 628–37, discussion 637–8. doi:10.1097/00006123-200209000-00006. PMID 12188940. S2CID 20678448.

usp.org

USP 32 (2008). "Mannitol Injection" (PDF). Archived from the original (PDF) on 6 July 2010. Retrieved 31 January 2010.{{cite web}}: CS1 maint: numeric names: authors list (link)

vice.com

"Cut the Shit". December 2005. Archived from the original on 27 September 2016. Retrieved 4 September 2017.

wada-ama.org

"THE 2017 PROHIBITED LIST INTERNATIONAL STANDARD" (PDF). January 2017. p. 5. Retrieved 7 July 2018.

web.archive.org

Varzakas T, Labropoulos A, Anestis S (2012). Sweeteners: Nutritional Aspects, Applications, and Production Technology. CRC Press. pp. 59–60. ISBN 9781439876732. Archived from the original on 10 September 2017.
"Mannitol". The American Society of Health-System Pharmacists. Archived from the original on 26 May 2015. Retrieved 8 January 2015.
Kremers E, Sonnedecker G (1986). Kremers and Urdang's History of Pharmacy. Amer. Inst. History of Pharmacy. p. 360. ISBN 9780931292170. Archived from the original on 10 September 2017.
"Select Committee on GRAS Substances (SCOGS) Opinion: Mannitol". FDA.gov. April 2013. Archived from the original on 22 October 2014.
Ellis FW, Krantz JC (1941). "Sugar alcohols: XXII. Metabolism and toxicity studies with mannitol and sorbitol in man and animals". J. Biol. Chem. 141: 147–154. doi:10.1016/S0021-9258(18)72829-9. Archived from the original on 10 September 2017.
"Cut the Shit". December 2005. Archived from the original on 27 September 2016. Retrieved 4 September 2017.
British Pharmacopoeia Commission Secretariat (2009). "Index, BP 2009" (PDF). Archived from the original (PDF) on 11 April 2009. Retrieved 31 January 2010.
"Japanese Pharmacopoeia, Fifteenth Edition" (PDF). 2006. Archived from the original (PDF) on 22 July 2011. Retrieved 31 January 2010.
USP 32 (2008). "Mannitol Injection" (PDF). Archived from the original (PDF) on 6 July 2010. Retrieved 31 January 2010.{{cite web}}: CS1 maint: numeric names: authors list (link)

zenodo.org

Domac J (1881). "Über das Hexylen aus Mannit". Monatshefte für Chemie (in German). 2: 309–322. doi:10.1007/BF01516516. S2CID 94940823.
Domac J (1882). "II. Ueber die Einwirkung der Unterchlorsäure auf Hexylen". Justus Liebig's Annalen der Chemie (in German). 213: 124–132. doi:10.1002/jlac.18822130107.